I am a
Home I AM A Search Login

Papers of the Week


2021


Front Oncol


11

The SPOP-ITCH Signaling Axis Protects Against Prostate Cancer Metastasis.

Authors

Ma J, Cai M, Mo Y, Fried JS, Tan X, Ma Y, Chen J, Han S, Xu B
Front Oncol. 2021; 11:658230.
PMID: 34322378.

Abstract

Prostate cancer is one of the most common causes of cancer incidence and death in men, with the mortality caused primarily by the late-stage and metastatic forms of the disease. The mechanisms and molecular markers for prostate cancer metastasis are not fully understood. Speckle type Poz Protein (SPOP) is an E3 ubiquitin ligase adaptor that is often mutated in prostate cancer. In this study, we sequenced the gene in 198 prostate cancer patients and found 16 mutations in the cohort. Multivariate analysis revealed that mutations correlated with the clinical stage of the disease and strongly with metastasis. We identified ITCH as a candidate protein for SPOP-mediated degradation mass spectrometry. We demonstrated the interaction between SPOP and ITCH, and found that the F133L mutation disrupted the SPOP-ITCH interaction, leading to a subsequent increase in the ITCH protein level. Further, we found that the SPOP knockdown led to higher levels of Epithelial- mesenchymal transition (EMT) proteins and increased cell invasion. Together, our results highlight the functional significance of the SPOP-ITCH pathway in prostate cancer metastasis.